USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:44 PM 2012

NYSE 8093.66 10.68 Index Moved Up

NASDAQ 2928.82 12.96 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and NAII...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Natural Alternatives Internati

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Natural Alternatives Internati in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.1

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Suggest

48.96

Intraday

One Month

^(0.26)

0.53%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.895B	Volume	149920
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.53%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.26
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

10.42

Intraday

One Month

^0.02

0.19%

NAII

NGM

Natural Alternatives Internati

P/E	13.00	P/B Ratio	1.95
Open	10.39	Day Low	10.27
Market Cap	72.6M	Volume	9850
Last Close	10.40	Short Ratio	0.80
Last Traded	2/9/2012	Year High	11.00
Percent Change	0.19%	EBITDA	8.6M
Year Low	3.00	Absolute Change	0.02
Book Value	5.341	EPS	0.80
Day High	10.47	Target Price	Not Applicable
Current EPS	0.80	This Year EPS	Not Applicable
Current PE	13.00	This Year PE	Not Applicable

Natural Alternatives International, Inc. Announces Texas Suits Against BPI ...

MarketWatch (press release) - Jan 24, 2012

SAN MARCOS, Calif., Jan. 24, 2012 /PRNewswire via COMTEX/ -- Natural Alternatives International, Inc. ("NAI") /quotes/zigman/55274/quotes/nls/naii NAII +1.44% , a leading formulator, manufacturer and marketer of customized nutritional supplements, ...

2012-01-24

Natural Alternatives International, Inc. Announces Texas Suits Against BPI Sports Holdings, LLC And Image Sports, LLC For Infringement Of Newly-Issued Patent Protecting CarnoSyn Beta-Alanine

Reuters Key Development - Jan 24, 2012

2012-01-24

Top 10 Rebounding Pharmaceutical Stocks: AEN, GEVA, TSPT, QCOR, NAII, FOLD ...

China Analyst - Jan 23, 2012

Adeona Pharmaceuticals, Inc. (AMEX:AEN) is the 1st best rebounding stock in this segment of the market. It has risen 417% from its 52-week low.

2012-01-23

Natural Alternatives International, Inc. Announces Texas Suit Against Woodbolt Distribution, LLC And Two Of Its Contract Manufacturers

Reuters Key Development - Dec 22, 2011

2011-12-22